Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 8.298M
March 31, 2026 16.35M
December 31, 2025 6.058M
September 30, 2025 6.646M
June 30, 2025 13.25M
March 31, 2025 10.34M
December 31, 2024 6.679M
September 30, 2024 3.681M
June 30, 2024 5.045M
March 31, 2024 3.924M
December 31, 2023 4.566M
September 30, 2023 4.195M
June 30, 2023 5.859M
March 31, 2023 8.623M
December 31, 2022 7.868M
September 30, 2022 7.439M
June 30, 2022 8.590M
Date Value
March 31, 2022 8.949M
December 31, 2021 8.832M
September 30, 2021 8.519M
June 30, 2021 10.07M
March 31, 2021 7.939M
December 31, 2020 5.659M
September 30, 2020 10.21M
June 30, 2020 4.552M
March 31, 2020 5.003M
December 31, 2019 6.940M
September 30, 2019 6.585M
June 30, 2019 3.478M
March 31, 2019 1.126M
December 31, 2018 1.277M
September 30, 2018 0.2219M
June 30, 2018 0.2341M
March 31, 2018 1.702M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Numinus Wellness, Inc. 4.668M
Cocrystal Pharma, Inc. 3.605M
Edesa Biotech, Inc. 3.91M
CNBX Pharmaceuticals, Inc. 2.672M
Invion Ltd. --

Total Liabilities (Quarterly) Related Metrics